Literature DB >> 15273450

Maximum P-wave duration and P-wave dispersion predict recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.

Kudret Aytemir1, Basri Amasyali, Sedat Kose, Ayhan Kilic, Gulcan Abali, Ali Oto, Ersoy Isik.   

Abstract

BACKGROUND: Identification of patients at risk for PAF recurrence after AP ablation is important because of the necessity for additional therapies.
OBJECTIVES: To determine whether Maximum P-wave duration (Pmax) and P-wave dispersion (Pd ) detected on surface ECG after successful accessory pathway (AP) ablation can predict the recurrence of paroxysmal atrial fibrillation (PAF).
METHODS: Seventy-eight patients with Wolff-Parkinson-White (WPW) syndrome who had at least one documented PAF episode and underwent catheter ablation were enrolled. Pmax, minimum P-wave duration (Pmin) and Pd were determined on a surface ECG recorded on a high resolution computer screen on day 2 after ablation of the AP.
RESULTS: There was no significant difference in terms of basic clinical data and electrophysiological findings between patients with (Group-1, n = 19) and without (Group-2, n = 59) recurrence of PAF during follow-up of 21 +/- 10 months. Pmax and Pd were significantly higher in Group-1 than Group-2 (120 +/- 15 vs. 96 +/- 10 ms and 47 +/- 12 vs. 25 +/- 7 ms, respectively; p < 0.001 for both). Pmin didn't differ significantly. A Pmax value of > or = 103 ms separated Group-1 from Group-2 with a sensitivity of 84.2%, specificity of 72.9%, positive predictive value of 50%, and negative predictive value of 93.5%. A Pd value of > or = 32.5 ms separated Group-1 from Group-2 with a sensitivity of 89.5%, specificity of 84.7%, positive predictive value of 65.4%, and negative predictive value of 96.2%. Pmax (p < 0.010) and Pd (p < 0.001) were found to be significant univariate predictors of PAF, whereas only Pd remained significant in multivariate analysis (p = 0.037).
CONCLUSION: Pd > or = 32.5 ms and Pmax > or = 103.0 ms predict the recurrence of PAF after ablation with acceptable positive and negative predictive values. Pd > or = 32.5 ms is an independent predictor of recurrence of PAF after catheter ablation in patients with WPW syndrome.

Entities:  

Mesh:

Year:  2004        PMID: 15273450     DOI: 10.1023/B:JICE.0000035925.90831.80

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  30 in total

1.  Seasonal variation of P-wave dispersion in healthy subjects.

Authors:  Sedat Kose; Kudret Aytemir; Ilknur Can; Atilla Iyisoy; Ayhan Kilic; Basri Amasyali; Hurkan Kursaklioglu; Ersoy Isik; Ali Oto; Ertan Demirtas
Journal:  J Electrocardiol       Date:  2002-10       Impact factor: 1.438

2.  Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway?

Authors:  O Fujimura; G J Klein; R Yee; A D Sharma
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Risk of stroke in non-rheumatic atrial fibrillation.

Authors:  K M Flegel; M J Shipley; G Rose
Journal:  Lancet       Date:  1987-03-07       Impact factor: 79.321

4.  P wave signal-averaged electrocardiography predicts recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome who underwent successful catheter ablation: a prospective study.

Authors:  Tatsuro Hiraki; Hisao Ikeda; Teruhisa Yoshida; Tomohito Inage; Masatsugu Ohe; Hitoshi Ohtsubo; Manabu Matsumoto; Takashi Hamada; Ichiro Kubara; Tsutomu Imaizumi
Journal:  J Cardiovasc Electrophysiol       Date:  2002-10

5.  P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation.

Authors:  K Aytemir; N Ozer; E Atalar; E Sade; S Aksöyek; K Ovünç; A Oto; F Ozmen; S Kes
Journal:  Pacing Clin Electrophysiol       Date:  2000-07       Impact factor: 1.976

Review 6.  P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation.

Authors:  P E Dilaveris; J E Gialafos
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-04       Impact factor: 1.468

7.  Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.

Authors:  L E Waspe; R Brodman; S G Kim; J D Fisher
Journal:  Am Heart J       Date:  1986-12       Impact factor: 4.749

8.  Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome.

Authors:  C Rinne; G J Klein; A D Sharma; R Yee; S Milstein; M F Rattes
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

9.  Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways.

Authors:  M Haissaguerre; B Fischer; T Labbé; P Lemétayer; P Montserrat; C d'Ivernois; J F Dartigues; J F Warin
Journal:  Am J Cardiol       Date:  1992-02-15       Impact factor: 2.778

10.  Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation.

Authors:  G Hindricks; H Kottkamp; X Chen; S Willems; G Breithardt; M Borggrefe
Journal:  Eur Heart J       Date:  1995-07       Impact factor: 29.983

View more
  9 in total

1.  A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: comparisons of sympathetic activity and left atrial size.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Fumito Miyoshi; Hui-Ling Li; Norikazu Watanabe; Taku Asano; Kaoru Tanno; Jumpei Suyama; Atsuo Namiki; Takehiko Gokan; Youichi Kobayashi
Journal:  J Interv Card Electrophysiol       Date:  2013-09-13       Impact factor: 1.900

Review 2.  Atrial Fibrillation in the Wolff-Parkinson-White Syndrome.

Authors:  Osmar Antonio Centurion
Journal:  J Atr Fibrillation       Date:  2011-05-04

3.  Predictors of early recurrence and delayed cure after segmental pulmonary vein isolation for paroxysmal atrial fibrillation without structural heart disease.

Authors:  Hong Jiang; Zhibing Lu; Handong Lei; Dongdong Zhao; Bo Yang; Congxin Huang
Journal:  J Interv Card Electrophysiol       Date:  2006-09-06       Impact factor: 1.900

4.  P wave dispersion predicts recurrence of paroxysmal atrial fibrillation in patients with atrioventricular nodal reentrant tachycardia treated with radiofrequency catheter ablation.

Authors:  Basri Amasyali; Sedat Kose; Kudret Aytemir; Ayhan Kilic; Hasan Turhan; Turgay Celik; Hurkan Kursaklioglu; Atila Iyisoy; Cengiz Ozturk; Ersoy Isik
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-07       Impact factor: 1.468

Review 5.  P wave indices: current status and future directions in epidemiology, clinical, and research applications.

Authors:  Jared W Magnani; Mary Ann Williamson; Patrick T Ellinor; Kevin M Monahan; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

6.  P-wave dispersion: What we know till now?

Authors:  Sercan Okutucu; Kudret Aytemir; Ali Oto
Journal:  JRSM Cardiovasc Dis       Date:  2016-03-21

7.  Advanced interatrial block predicts recurrence of atrial fibrillation after accessory pathway ablation in patients with Wolff-Parkinson-White syndrome.

Authors:  Jin-Tao Wu; Dan-Qing Zhao; Fei-Fei Li; Rui Wu; Xian-Wei Fan; Guang-Ling Hu; Min-Fu Bai; Hai-Tao Yang; Li-Jie Yan; Jing-Jing Liu; Xian-Jing Xu; Shan-Ling Wang; Ying-Jie Chu
Journal:  Clin Cardiol       Date:  2019-06-26       Impact factor: 2.882

8.  Atrial Fibrillation and Beta Thalassemia Major: The Predictive Role of the 12-lead Electrocardiogram Analysis.

Authors:  Vincenzo Russo; Anna Rago; Bruno Pannone; Andrea Antonio Papa; Maria Carolina Mayer; Anna Spasiano; Raffaele Calabro; Maria Giovanna Russo; Nigro Gerardo
Journal:  Indian Pacing Electrophysiol J       Date:  2014-05-25

9.  Doxycycline Improves Fibrosis-Induced Abnormalities in Atrial Conduction and Vulnerability to Atrial Fibrillation in Chronic Intermittent Hypoxia Rats.

Authors:  Zuowang Ma; Kai Zhang; Yun Wang; Weiding Wang; Yu Yang; Xue Liang; Yue Zhang; Guangping Li
Journal:  Med Sci Monit       Date:  2020-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.